Skip to main content
Clinical Trials/NCT03635658
NCT03635658
Unknown
N/A

Assessment of Guided Bone Regeneration in Augmentation of Horizontally Atrophic Maxillary Ridge Using Collagen Membrane Versus Using Titanium Mesh: a Randomized Controlled Clinical Trial

Cairo University0 sites20 target enrollmentOctober 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Horizontal Ridge Deficiency
Sponsor
Cairo University
Enrollment
20
Primary Endpoint
membrane exposure
Last Updated
7 years ago

Overview

Brief Summary

this study is aiming to Assess postoperative complications and bone quality and quantity in augmentation of horizontally atrophic maxillary ridge using a 1:1 mixture of autograft and xenograft particulate bone covered with collagen membrane with the new Sausage technique™ versus using the same mixture covered with titanium mesh.

Detailed Description

patients with atrophic maxillary ridge \< 4 mm will be selected in this study for augmentation for future implant placement. The full thickness flap will be elevated including one extra tooth on each side of the edentulous area or if completely edentulous 5 mm on each side.. the bone bed will be prepared by cleaning any debris and Multiple decortication holes will be performed with a 2.0 mm round bur. the harvested bone from the chin is then mixed with the xenograft with ratio 1:1 and then put on the recipient site and will be covered with a collagen membrane with the Sausage technique (intervention group) and the other group the graft will be covered with titanium mesh (control group). flap is repositioned and sutured. followup for 6 months and then CBCT is done. Reopening after 6 months, core biopsy is taken by a 2 mm thickness trephine from the healed augmented bone at the site of implant placement and will be sent for histomorphometric analysis and the bone thickness (buccolingual ) dimension is measured using a caliper and from the CBCT (cone beam CT) the bone width gain will be calculates and recorded. postoperative complications( infection, wound dehiscence or membrane exposure) will be monitored and recorded.

Registry
clinicaltrials.gov
Start Date
October 1, 2018
End Date
October 1, 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Randa khaled Ismail

assistant lecturer in oral and maxillofacial department cairo university

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients with horizontal atrophied maxillary ridge (thin ridge) less than 4mm.
  • All ages and both sexes were included in this study.
  • Patients should be free from any systemic disease that may affect normal healing of bone, and predictable outcome.
  • Patients with physical and psychological tolerance

Exclusion Criteria

  • Patients with high risk systemic diseases like uncontrolled diabetes mellitus. As uncontrolled diabetes mellitus has a negative impact on normal bone healing. 8
  • Heavy smokers.4
  • Alcohol or drug abuse
  • Gingival bleeding or full mouth plaque index ≥ 25%.4
  • Patients with physical and psychological intolerance. As psychological stress will affect the immune system and patient's fitness including healing capacity. 9
  • Unavailability for regular follow-ups

Outcomes

Primary Outcomes

membrane exposure

Time Frame: within 3 weeks

clinical postoperative complications as flap dehiscence and membrane exposure into the oral cavity, its a binary outcome (yes/No) examined and recorded by the investigator.

infection

Time Frame: 10 days

suppuration collection related to the membrane and flap, its a binary outcome (yes/No) examined and recorded by the investigator.

inflammation

Time Frame: 10 days

redness and tenderness of the flap, its a binary outcome (yes/No) examined and recorded by the investigator.

Secondary Outcomes

  • bone width gain(at 6 months)
  • bone quality(at 6 months)

Similar Trials